Search Results 531-540 of 16677 for Psychogenic
Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6- ...
In support of this hypothesis, the lab has determined that genetic variants near many genetic risk loci for late-onset Alzheimer's disease associate with brain ...
Learn about the experts and services, including awake brain surgery, available for the diagnosis and treatment of brain and central nervous system tumors.
Research in Dr. Jurk's Biology of Aging and Age-Related Diseases Lab is examining how senescence contributes to various diseases related to aging.
Madhavan AA, Lutzen N, Cutsforth-Gregory JK, Schievink WI, Kodet ML, Mark IT, Morris PP, Messina SA, Wald JT, Brinjikji W. Additional Diagnostic Value of ...
The goal of this clinical trial is to identify the specific characteristics (phenotypes) that may be useful to help select the right medication for weight loss, ...
About this study. The purpose of this study is to evaluate whether treatment with JNJ-54861911 slows cognitive decline compared with placebo treatment, ...
Cortez GM, Monteiro A, Ludwig B, Hanel R. Reappraisal of haemorrhagic suprasellar pilocytic astrocytoma during adulthood. BMJ Case Rep. 2020 Oct 29; 13 (10)
Brain rehabilitation can help with common challenges such as speech, mobility and daily care after a stroke or other brain injury.
This is an intervention targeting patients at risk for non-adherence to endocrine therapy after primary treatments for hormone-positive breast cancer. In a ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.